red blood cell transfusion การใช้

• If needed, red blood cell transfusions or erythropoietin can be used for management of anemia.
• In a phase II randomised trial in patients with acute trauma, this product reduced the required number of allogeneic red blood cell transfusions.
• These have included the use of corticosteroids for respiratory distress, red blood cell transfusions for anemia, pericardial tamponades, and other standard treatments.
• Leukine helps the body rebuild its stores of infection-fighting white blood cells and reduces the number of platelet and red blood cell transfusions needed.
• While claiming the results show Hemopure reduces the need for red blood cell transfusions and is just as safe, the data has come out in dribs and drabs.
• The risk of severe bacterial infection is estimated, as of 2002, at about 1 in 50, 000 platelet transfusions, and 1 in 500, 000 red blood cell transfusions.
• Because of its ability to deliver oxygen, Rausch said, Hemopure potentially could be used in combination with red blood cell transfusions as well as in situations for which red blood cells are not well-suited.
• Biopure Corp . is expected to announce Wednesday that it is the first company to complete enrolling patients in a pivotal US clinical trial that compares the safety and efficacy of a hemoglobin-based blood substitute to red blood cell transfusion.
• Thus far, there are no well-accepted " oxygen-carrying " blood substitutes, which is the typical objective of a red blood cell transfusion; however, there are widely available non-blood volume expanders for cases where only volume restoration is required.
• Lenalidomide was approved on June 17, 2013 by the European Medicines Agency for use in low-or intermediate-1-risk myelodysplastic syndromes ( MDS ) patients who have the deletion 5q cytogenetic abnormality and no other cytogenetic abnormalities, are dependent on red blood cell transfusions, and for whom other treatment options have been found to be insufficient or inadequate.
• "For us and many of the companies that did their phase 3 clinical trials, this is the year the rubber meets the road as we have real products that will make a difference, creating revenues and profits, " said Carl Rausch, chief executive of Biopure Corp . Biopure plans to seek FDA approval later this year for Hemopure, its bovine-based alternative to red blood cell transfusion in orthopedic surgery patients.